Immunovant (IMVT) Non Operating Income (2023 - 2026)
Immunovant (IMVT) posted Non Operating Income of $8.1 million for Q1 2026, up 51.06% on a QoQ basis from $5.3 million in Q4 2025, and up 16.96% year-over-year from $6.9 million in Q1 2025.
Immunovant (IMVT) Non Operating Income (2023 - 2026) Analysis & Trends
Immunovant's Non Operating Income history runs 4 years deep, the most recent figure standing at $8.1 million for Q1 2026.
- Quarterly Non Operating Income rose 16.96% year-over-year to $8.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.3 million (up 2.42% YoY) and the FY2026 annual result came in at $25.3 million, up 2.42% from the prior year.
- Non Operating Income was $8.1 million for Q1 2026 at Immunovant, up from $5.3 million in the prior quarter.
- Across five years, Non Operating Income topped out at $8.9 million in Q4 2023 and bottomed at $3.6 million in Q3 2023.
- A 4-year average of $6.3 million and a median of $6.2 million in 2024 frame the typical range for Non Operating Income.
- Peak annual rise in Non Operating Income reached 76.63% in 2024, while the deepest fall reached 48.62% in 2024.
- Immunovant's Non Operating Income stood at $8.9 million in 2023, then plunged by 48.62% to $4.6 million in 2024, then grew by 16.19% to $5.3 million in 2025, then jumped by 51.06% to $8.1 million in 2026.
- Business Quant data shows IMVT's Non Operating Income at $8.1 million in Q1 2026, $5.3 million in Q4 2025, and $5.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Immunovant | 7.17 Bn | 7.17 Bn | - | 8.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.06 Mn |
| Dec 31, 2025 | 5.33 Mn |
| Sep 30, 2025 | 5.60 Mn |
| Jun 30, 2025 | 6.34 Mn |
| Mar 31, 2025 | 6.89 Mn |
| Dec 31, 2024 | 4.59 Mn |
| Sep 30, 2024 | 6.07 Mn |
| Jun 30, 2024 | 7.18 Mn |
| Mar 31, 2024 | 8.38 Mn |
| Dec 31, 2023 | 8.93 Mn |
| Sep 30, 2023 | 3.57 Mn |
| Jun 30, 2023 | 4.07 Mn |